Pretreatment central quality control for craniospinal irradiation in non-metastatic medulloblastoma
ConclusionThis prospective pretreatment individual case review study revealed a high rate of deviations and emphasizes the strong need of pretreatment RT-QC in clinical trials for medulloblastoma. Furthermore, the experiences point out the necessity of new RT-QC criteria for high-precision CSI techniques.
Source: Strahlentherapie und Onkologie - Category: Cancer & Oncology Source Type: research
More News: Austria Health | Cancer & Oncology | Clinical Trials | Germany Health | Medulloblastoma | Study | Switzerland Health